New knee cartilage repair technique shows promise in early trial

NCT ID NCT07641868

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two surgical methods for repairing damaged knee cartilage: the standard microfracture procedure and a newer technique called minced cartilage implantation (MCI). In MCI, a patient's own cartilage is chopped into tiny pieces and reimplanted with platelet-rich plasma to stimulate better healing. The trial will enroll 80 adults with focal cartilage lesions and measure repair quality via MRI at 24 months, along with pain and function scores.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Minced cartilage implantation (MCI) with platelet-rich plasma (PRP)
What this could lead to
If MCI works better than microfracture, it could offer a more effective surgical option for repairing knee cartilage and reducing pain.
What could go wrong
This is an early-stage trial with only 80 participants, and results may not apply to everyone. MCI is a surgical procedure with typical risks like infection or incomplete healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Feb 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female, aged over 18 years. * Patient who has signed an informed consent form. * Patient with focal cartilage lesions of the knee, classified as grade 4 on MRI according to the International Cartilage Repair Society classification (exposure of subchondral bone), regardless of size, and for which surgery is indicated. * Be affiliated with or a beneficiary of a social security scheme. Exclusion Criteria: * Revision knee surgery * Body Mass Index (BMI) \> 27 kg/m² * Joint space narrowing on standard radiographic examination * Refusal of consent * Patient unable to read, write, or understand French * Vulnerable patient according to Article L1121-6 of the French Public Health Code (CSP) * Adult patient under guardianship, curatorship, or legal protection * Patient unable to give Personally, their consent according to Article L.1121-8 of the French Public Health Code (CSP) or an adult protected by law * Pregnant or breastfeeding woman according to Article L1121-5 of the French Public Health Code (CSP) * Patient who has already participated in a study within the last 12 months * Patient already enrolled in another ongoing clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Focal cartilage lesions of the knee are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fractures, Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clinique Louis Pasteur - Louis Pasteur Santé Lorraine

    Essey-lès-Nancy, Grand Est, 54270, France